Glinate 60 Tablet contains Nateglinide 60mg, an oral antihyperglycemic agent used in the management of type 2 diabetes mellitus. Nateglinide belongs to the meglitinide class of insulin secretagogues, which stimulate rapid and short-duration insulin release from pancreatic beta cells by closing ATP-dependent potassium channels. This mechanism helps to control postprandial blood glucose levels effectively. Glinate 60 is indicated as an adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes, particularly those with inadequate control on diet alone or in combination with other antidiabetic agents. The rapid onset and short duration of action make Nateglinide suitable for administration before meals to reduce post-meal hyperglycemia without causing prolonged hypoglycemia. It is important to monitor blood glucose levels regularly during therapy to adjust dosage accordingly and to avoid hypoglycemic episodes. Glinate 60 should be used cautiously in patients with hepatic or renal impairment, and it is contraindicated in patients with type 1 diabetes or diabetic ketoacidosis. Common adverse effects include hypoglycemia, gastrointestinal disturbances, and allergic reactions. Patient adherence to prescribed diet, exercise, and medication regimen is essential for optimal therapeutic outcomes.